Feedback / Questions
Yesintek (ustekinumab-kfce) - Biocon, Yoshindo
https://www.business-standard.com/markets/capital-market-news/biocon-s-biologics-arm-gets-health-canada-approval-for-monoclonal-antibody-drug-yesintek-125102300447_1.html
Oct 23, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next